Post-approval studies (Phase 4)Study completedNCT01756079
What this trial is testing
Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105)
Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 58